The mechanisms responsible for the relationship between MetS and an increased risk of cancer death remain unclear; however, potential factors include obesity, insulin resistance, and the insulin-like growth factor (IGF) system [40]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.